Global strategic collaboration with Astellas to advance PSMA-targeted, PRO-XTEN® dual-masked T-cell engager (TCE) VIR-5500 ...

Cochlear, CSL and Pro Medicus have been hard hit by disparate concerns, many of which investors suspect are structural rather ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the Bank of America Securities 2026 ...

On Saturday, Rami Elghandour learned that the university had canceled his speech after complaints over his social media posts ...

On April 16, 2026, Vir Biotechnology, Inc. announced the closing of its global collaboration and licensing agreement with Astellas for VIR-5500 in metastatic prostate cancer, securing a US$240,000,000 ...

The biotech graveyard is full of approved drugs the market never believed in. After years of hype cycles and clinical failures, investors have learned to discount early launches — especially in rare ...

Rami Elghandour tells Guardian in exclusive interview his speech was cancelled due to students’ complaints ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on ...

Biotech interviews in 2026 demand more than just lab expertise—they assess critical thinking, communication, and the ability to operate within regulatory and fast-paced environments. Employers seek ...

(JTA) — Administrators at Rutgers University have canceled a commencement speaker scheduled for next week, citing an ...

President Donald Trump has signed off on a plan to oust US Food and Drug Administration Commissioner Dr. Marty Makary, ...

Praxis Precision Medicines Inc. will report first-quarter results before the market opens Thursday, a closely watched financial snapshot for a pre-revenue biotechnology company racing to transform ...